ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
NOVOZYMES A/S: cashflow_investing
One fact, its scope and the complete path back to the official record.
Reported value
-2.133B{"amount": -2133000000.0, "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities"}- Entity
- NOVOZYMES A/S
- Metric
- cashflow_investing
- Period
- 2023-01-01 – 2023-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:529900T6WNZXD2R3JW38:2023-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-23T23:50:02.590649+02:00
Raw response SHA-256
6155c534b334fafbbfc9db117d357491…History
- supersedes {"amount": -286200000.0, "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities"} (evidence esef:529900T6WNZXD2R3JW38:2024-12-31)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.